83 related articles for article (PubMed ID: 1493453)
41. Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease.
Bierman PJ; Vose JM; Leichner PK; Quadri SM; Armitage JO; Klein JL; Abrams RA; Dicke KA; Vriesendorp HM
J Clin Oncol; 1993 Apr; 11(4):698-703. PubMed ID: 8478663
[TBL] [Abstract][Full Text] [Related]
42. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
43. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Majolino I; Pearce R; Taghipour G; Goldstone AH
J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
[TBL] [Abstract][Full Text] [Related]
44. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
[TBL] [Abstract][Full Text] [Related]
45. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
[TBL] [Abstract][Full Text] [Related]
46. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
[TBL] [Abstract][Full Text] [Related]
47. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
48. High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.
Jones RJ; Piantadosi S; Mann RB; Ambinder RF; Seifter EJ; Vriesendorp HM; Abeloff MD; Burns WH; May WS; Rowley SD
J Clin Oncol; 1990 Mar; 8(3):527-37. PubMed ID: 2307990
[TBL] [Abstract][Full Text] [Related]
49. High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's disease.
Fleury J; Legros M; Colombat P; Cure H; Travade P; Tortochaux J; Dionet C; Chollet P; Linassier C; Lamagnere JP; Blaise D; Viens P; Maraninchi D; Plagne R
Leuk Lymphoma; 1996 Jan; 20(3-4):259-66. PubMed ID: 8624465
[TBL] [Abstract][Full Text] [Related]
50. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.
Verdonck LF; van Putten WL; Hagenbeek A; Schouten HC; Sonneveld P; van Imhoff GW; Kluin-Nelemans HC; Raemaekers JM; van Oers RH; Haak HL
N Engl J Med; 1995 Apr; 332(16):1045-51. PubMed ID: 7898521
[TBL] [Abstract][Full Text] [Related]
51. Role of chemoresistance prior to autologous bone marrow transplantation for Hodgkin's disease.
Voillat L; Deconinck E; Flesch M; Brion A; Rozenbaum A; Vuillier J; Pavy JJ; Angonin R; Carbillet JP; Hervé P
Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):423-30. PubMed ID: 7753613
[TBL] [Abstract][Full Text] [Related]
52. Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease.
Yahalom J; Gulati SC; Toia M; Maslak P; McCarron EG; O'Brien JP; Portlock CS; Straus DJ; Phillips J; Fuks Z
J Clin Oncol; 1993 Jun; 11(6):1062-70. PubMed ID: 8501492
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
Smith RS; Chen Q; Hudson MM; Link MP; Kun L; Weinstein H; Billett A; Marcus KJ; Tarbell NJ; Donaldson SS
J Clin Oncol; 2003 May; 21(10):2026-33. PubMed ID: 12743158
[TBL] [Abstract][Full Text] [Related]
54. Hodgkin's lymphoma: evolving concepts with implications for practice.
Meyer RM; Ambinder RF; Stroobants S
Hematology Am Soc Hematol Educ Program; 2004; ():184-202. PubMed ID: 15561683
[TBL] [Abstract][Full Text] [Related]
55. Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: a retrospective study.
Ali A; Sayed H; Farrag A; El-Sayed M
Leuk Res; 2010 Nov; 34(11):1447-52. PubMed ID: 20599270
[TBL] [Abstract][Full Text] [Related]
56. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
57. Reevaluation of prognostic significance of symptoms in Hodgkin's disease.
Gobbi PG; Cavalli C; Gendarini A; Crema A; Ricevuti G; Federico M; Di Prisco U; Ascari E
Cancer; 1985 Dec; 56(12):2874-80. PubMed ID: 4052959
[TBL] [Abstract][Full Text] [Related]
58. Identification of prognostic groups in follicular lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Party.
Cameron DA; Leonard RC; Mao JH; Prescott RJ
Leuk Lymphoma; 1993 May; 10(1-2):89-99. PubMed ID: 8374528
[TBL] [Abstract][Full Text] [Related]
59. A Guide on Management: PREPARED BY A WORKING PARTY IN THE DEPARTMENT OF CHILD HEALTH, UNIVERSITY OF NEWCASTLE UPON TYNE.
Br Med J; 1973 Dec; 4(5893):657-60. PubMed ID: 20791927
[No Abstract] [Full Text] [Related]
60. Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study.
Lia K; Jørgensen RRK; L Wold B; Fluge Ø; Fagerli UM; Bersvendsen H; Bø IB; Bhargava S; Fosså A
Haematologica; 2024 May; 109(5):1403-1412. PubMed ID: 37881879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
